Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2005
09/22/2005WO2005086895A2 Ion channel modulators
09/22/2005WO2005086892A2 Ion channel modulators
09/22/2005WO2005086656A2 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
09/22/2005WO2005056547A3 Quinoxalines useful as inhibitors of protein kinases
09/22/2005WO2005047270A3 Substituted triazoles as sodium channel blockers
09/22/2005WO2005016876A3 Cyclic amine bace-1 inhibitors having a benzamide substituent
09/22/2005US20050209464 Dyeing composition; oxidation-dyeing keratin fibers
09/22/2005US20050209456 Vascular endothelial growth factor; tyrosine kinase inhibitor; angiogenesis inhibitor; anticancer agents
09/22/2005US20050209450 High yield for industrial production; beta -lactam antibacterial agents; allyl (5R,6S)-6((R)-1-t-butyldimethyl-silyloxyethyl)-7-oxo-3-((R)-2-tetrahydrofuryl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate (3-2)
09/22/2005US20050209302 Glycogen synthase kinase (GSK-3) inhibitors; diabetes, neurodegenerative diseases, stroke, neurotraumatic injuries and bipolar disorders; 5-acetyl-3-[3-(methoxycarbonylpropylamino)-(benzo-[1.3]dioxyo-5-yl)-methylidene]-2-indolinone for example
09/22/2005US20050209282 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia
09/22/2005US20050209260 Purinergic receptor antagonists; genitourinary and pain-related diseases; for example, 5-(2-isopropyl-4,5-dimethoxybenzyl)-pyrimidine-2,4-diamine
09/22/2005US20050209255 Compositions useful as inhibitors of protein kinases
09/22/2005US20050209249 Use as antidiabetic agents, treating hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis; (3S, 5S)-4-([5-(Thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-sulfamoyl)-benzoic acid for example
09/22/2005US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors
09/22/2005US20050209232 Useful for treating inflammatory, immunological, and integrin-mediated disorders such as inflammatory bowel disease; 2-(3,3-Diisopropyl-ureido)-3-[4-(5-methoxy-2-methyl-3-oxo-2,3-dihydro-pyridazin-4-yl)-phenyl]-propionic acid for example
09/22/2005US20050209231 In embryonic stem cells in vitro and in vivo; cardiomyopathy; 2,6-diaminopyrimidine compounds
09/22/2005US20050209230 2,4-Pyrimidinediamine compounds and their uses
09/22/2005US20050209225 Substituted indoles and their use as integrin antagonists
09/22/2005US20050209224 N4-(4H-5-pyrid[1,4]oxazin-6-yl)-2,4-pyrimidinediamine derivatives; for treating rheumatoid arthritis
09/22/2005US20050209223 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections
09/22/2005US20050209217 3-Mercaptopyrrolidines as farnesyl protein transferase inhibitors
09/22/2005US20050209215 Reacting 2-(11H-dibenz[b,e]azepin-6-ylmethyl)-1H-isoindole-1,3(2H)-dione with a metal hydride or a metal hydride complex (sodium borohydride); antiallergic and antihistamine; hydrazine free
09/22/2005US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209212 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; improvement over imipenem
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005US20050209195 Derivatives of compound 1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-2H-indol-2-one; Antitumor agents; tyrosine kinase inhibitors
09/22/2005US20050209106 Herbicides; selectively controlling broad-leaved weeds and weed grasses in crops of useful plants; 6-ethyl-4-(4-trifluoromethyl-1H-1-pyrazolyl)-2-(2-trifluoromethylpyridin-4-yloxy)pyrimidine
09/22/2005US20050208582 Pyrazole compounds and pharmaceutical compositions comprising the compound
09/22/2005CA2559143A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005CA2559139A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005CA2559115A1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments
09/22/2005CA2558552A1 Sulphonylpyrroles as hdac inhibitors
09/22/2005CA2558243A1 Inhibitors of histone deacetylase
09/22/2005CA2558217A1 Ion channel modulators
09/22/2005CA2558214A1 Ion channel modulators
09/22/2005CA2558036A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005CA2558034A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005CA2557672A1 Ion channel modulators
09/22/2005CA2557665A1 Ion channel modulators
09/22/2005CA2557648A1 Ion channel modulators
09/22/2005CA2557642A1 Ion channel modulators
09/22/2005CA2557637A1 Ion channel modulators
09/22/2005CA2557527A1 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
09/22/2005CA2557247A1 Compounds as inhibitors of hepatitis c virus ns3 serine protease
09/21/2005EP1577296A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their use
09/21/2005EP1577295A1 Process for preparing 2-oxo-1-pyrrolidine derivatives as intermediates
09/21/2005EP1576159A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
09/21/2005EP1575963A1 Therapeutic agents
09/21/2005EP1575942A1 Novel compounds having selective inhibiting efect at gsk3
09/21/2005EP1575940A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
09/21/2005EP1575939A1 Novel compounds having selective inhibiting effect at gsk3
09/21/2005EP1575934A1 Carbazole derivatives and their use as npy-5 antagonists
09/21/2005EP1575926A1 New pyridazin-3(2h)-one derivatives
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
09/21/2005EP1575924A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion
09/21/2005EP1575919A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
09/21/2005EP1575493A2 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1299382B1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
09/21/2005EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/21/2005CN1671717A Azole derivatives as antifungal agents
09/21/2005CN1671711A Calcitonin gene related peptide receptor antagonists
09/21/2005CN1671698A 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines
09/21/2005CN1671697A Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/21/2005CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors
09/21/2005CN1671693A Process for preparing indolinone derivatives
09/21/2005CN1671673A Copper-catalysed ligation of azides and acetylenes
09/21/2005CN1671672A Aryl substituted benzimidazoles and their use as sodium channel blockers
09/21/2005CN1671659A Novel substituted indoles
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1219763C Substituted indole mannich bases
09/21/2005CN1219517C Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/20/2005US6946555 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
09/20/2005US6946476 For therapy of metabolic and eating disorders such as obesity and hyperphagia, diabetes
09/20/2005US6946471 2-(2,6-Dichlorophenyl)-Diarylimidazoles
09/20/2005US6946468 that inhibit farnesylation of mutant ras gene products; cancer; (2)-2-(2-methoxy-ethyl)-1-((cis)-3-sulfanyl-pyrrolidin-2-ylmethyl)-4-naphthoyl-piperazine
09/20/2005US6946467 Serine protease inhibitors
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/15/2005WO2005085387A1 Material for organic electroluminescence device and organic electroluminescence device utilizing the same
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085235A1 Pyrazolyl indolyl derivatives as ppar activators
09/15/2005WO2005085232A1 Hydantoin derivatives for use as tace and aggrecanase inhibitors
09/15/2005WO2005085231A1 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives
09/15/2005WO2005085230A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
09/15/2005WO2005085226A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
09/15/2005WO2005085214A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005WO2005085212A1 Substituted pyrimidine derivative
09/15/2005WO2005085209A1 Basic amine compound and use thereof
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005WO2005085194A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
09/15/2005WO2005085177A2 Biaryl amino acids and their use in dna binding oligomers
09/15/2005WO2005084670A1 Pharmaceutical formulation
09/15/2005WO2005084669A1 Pharmaceutical composition
09/15/2005WO2005084667A1 Bicyclic and bridged nitrogen heterocycles
09/15/2005WO2005068433A9 Benzimidazole derivatives
09/15/2005WO2005063254A3 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 626